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Introduction
Gout is a common metabolic disorder, involving liver,
kidney and joints, it is met more often in men. Recently
we described specific ultrasound (US) signs of gout
nephropathy [1]. We suggest novel mathematical model
according to which the medical process is percepted as a
complex system like “black box” [2,3]. This process (dis-
ease progression) is described by some of the primary
indicators (US and laboratory biomarkers). So primary
indicators and output rate are stochastic in nature and
presented as statistical information. The “best” mathema-
tical model of the medical process is studied using a spe-
cial algorithm for processing statistical data [2].
The aim
was to assess the complex multiparameter evaluation of
biomarkers for diagnostic decision making in patients
with gout using novel mathematical model.
Materials and methods
We considered 42 patients (35 men, 7 women) to the
first group, mean age was 58 ± 4.5, whom gout was
diagnosed, according to disease history, or increased
levels of uric acid in blood. The average level of uric
acid in patients in group was 465 µmol/L. The control
group included 34 patients (16 men, 18 women), mean
age 54 ± 6 years without clinical, laboratory signs of
nephropathy and liver pathology. All patients underwent
ultrasound examination, gray scale, Doppler and sonoe-
lastography parameters of liver and kidneys were
recorded and evaluated statistically and assessed with
own model [3]. Integrated index (Y) rated ranged 0/1
for disease description and staging was calculated.
Results
In all patients of the first group were US signs of fatty
liver, in 38 patients (90%) ultrasonography signs of
nephropathy were registered, significantly more frequent
(P < 0.01) than in second group. The diffuse fatty liver
(P < 0.01) and portal hypertension (P < 0.1) were pre-
vailed in the first group. Transaminase increase was
registered only in 7 patients (17%) of the first group.
Nephropathy signs included thinning, increasing echo-
genicity of kidney parenchyma (P < 0.05), detection of
fibrotic changes and small hyperechoic inclusions, hilly
margins, anaechoic strips under the capsule, RI increas-
ing in segmental arteries over 0.7. The revealing of
nephropathy (r > 0.85) was correlated with creatinine
level increase and with liver fibrosis (r > 0.8). Additional
attributes were joint lesions (P < 0.01). Integrated index
Y was 0.73 in first group and 0.28 in second (P < 0.01).
Conclusions
Ultrasound can be an effective method for early detec-
tion of liver and kidneys involvement in gout patients
for performing their personalized treatment. The sensi-
tivity, specificity, positive and negative predictive value
and accuracy the gout involvement of liver and kidneys
using complex ultrasonography diagnostic criteria
were 92.6%, 84.4%, 80%, 95%, and 91.9% respectively.
Nephropathy appearance correlates with diffuse liver
* Correspondence: rostbubnov@gmail.com
† Contributed equally
1Clinical Hospital Pheophania, Center for ultrasound diagnosis and
interventional sonography, Kyiv, Ukraine
Full list of author information is available at the end of the article
Bubnov and Melnyk EPMA Journal 2014, 5(Suppl 1):A58
http://www.epmajournal.com/content/5/S1/A58
© 2014 Bubnov and Melnyk; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
involvement. Integrated index Y could be reliable for
disease staging and control treatment follow up.
Recommendations
It is recommended to create the system for complex
evaluation of biomarkers using suggested mathematical
model, based of patient medical records for prediction,
personalized treatment and prevention gout that may be
applicable in still existing closed medical system, obtain-
ing relevant extensive data.
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